JESSICA LOWERY: Open Payments
NPI 1396162715 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,140 in 287 payments from 31 companies in 2025. Trend: 2023 $3,503 · 2024 $5,798 · 2025 $6,140
Food & beverage: $6,070Education: $70
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 26 | $489 |
| SK Life Science, Inc. | 16 | $434 |
| ABBVIE INC. | 23 | $426 |
| Axsome Therapeutics, Inc. | 13 | $408 |
| Mallinckrodt Hospital Products Inc. | 14 | $373 |
| Lundbeck LLC | 20 | $355 |
| Genentech USA, Inc. | 14 | $302 |
| Teva Pharmaceuticals USA, Inc. | 12 | $284 |
| Biogen, Inc. | 14 | $276 |
| TG Therapeutics, Inc. | 14 | $239 |
Products named: ACTHAR, NURTEC ODT, VYEPTI, Leqembi, AJOVY, Ocrevus Zunovo, Symbravo, BRIUMVI.
Industry payments across MS — which companies pay providers there.
